Skip to main content
Equibles
KLRS $3.38 +2.42%
KLRS logo
KLRS · Kalaris Therapeutics, Inc.
Track KLRS — free

Use KLRS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KLRS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.38 +0.08 (+2.42%) At close · Sep 11
Rebalance outlook locked
Market Cap
$80.46M
Shares
23.80M
All earnings calls

Earnings call · FY2022 Q3

Kalaris Therapeutics, Inc. (KLRS) Q3 2022 Earnings Call

Concluded Nov 3, 2022
Nov 3, 2022 0 turns
Period
FY2022 Q3
Runtime
—
Sources
2 artifacts
8-K 10-Q

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Diluted EPS -$11.50
Net income -$42.07M

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Nov 3, 2022 10-Q report Filed Nov 3, 2022
Full-screen source Call document

KLRS transcript alerts

Kalaris Therapeutics, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →